ACROBiosystems (@acrobio) 's Twitter Profile
ACROBiosystems

@acrobio

An internationally recognized manufacturer of recombinant proteins and reagents to support the development of target therapeutics, vaccines, and diagnostics.

ID: 4717941553

linkhttps://www.acrobiosystems.com/ calendar_today06-01-2016 09:45:39

1,1K Tweet

1,1K Followers

2,2K Following

ACROBiosystems (@acrobio) 's Twitter Profile Photo

Accurate immunological research starts with the right isotype controls. Our IgG Isotype Controls, IgG Fc Proteins, and Recombinant Serum Albumin ensure precise, reliable data for every stage of drug development. smpl.is/9ms5s #DrugDevelopment #Immunology #Biotech

Accurate immunological research starts with the right isotype controls. Our IgG Isotype Controls, IgG Fc Proteins, and Recombinant Serum Albumin ensure precise, reliable data for every stage of drug development.

 smpl.is/9ms5s

#DrugDevelopment #Immunology #Biotech
ACROBiosystems (@acrobio) 's Twitter Profile Photo

Accelerate your ASO and siRNA drug development with our top-tier proteins and stable cell lines. Target screening, validation, and delivery system verification made easy. Discover more: smpl.is/9n4mf #Biotech #Oligonucleotides #DrugDevelopment

Accelerate your ASO and siRNA drug development with our top-tier proteins and stable cell lines. Target screening, validation, and delivery system verification made easy. Discover more: smpl.is/9n4mf 

#Biotech #Oligonucleotides #DrugDevelopment
ACROBiosystems (@acrobio) 's Twitter Profile Photo

Big wins in lipid-lowering therapies! 🧬 Recent PCSK9 updates: AstraZeneca, Akeso, Hengrui, Junshi. ACROBiosystems supports with PCSK9, ASGR1 & LDL-R proteins! smpl.is/9qm6a #PCSK9

Big wins in lipid-lowering therapies! 🧬 Recent PCSK9 updates: AstraZeneca, Akeso, Hengrui, Junshi. ACROBiosystems supports with PCSK9, ASGR1 & LDL-R proteins! smpl.is/9qm6a

#PCSK9
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🔬 IL-17A plays a crucial role in autoimmune diseases like psoriasis. Targeting it can reduce inflammation and improve patient outcomes. Explore our IL-17 family proteins to boost your drug development efforts! smpl.is/9rb7k #Biotech #IL17A #DrugDevelopment #Immunology

🔬 IL-17A plays a crucial role in autoimmune diseases like psoriasis. Targeting it can reduce inflammation and improve patient outcomes. Explore our IL-17 family proteins to boost your drug development efforts!  smpl.is/9rb7k #Biotech #IL17A #DrugDevelopment #Immunology
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🚀 Enhancing #Organoid research! iPSC-derived models for heart, brain, intestine & liver are transforming #DrugDiscovery, #DiseaseModeling & #PrecisionMedicine. Discover how we’re advancing preclinical research. 🧬acrobiosystems.com/A2398-Disease-… #Biotech #LifeSciences

🚀 Enhancing #Organoid research! iPSC-derived models for heart, brain, intestine & liver are transforming #DrugDiscovery, #DiseaseModeling & #PrecisionMedicine. Discover how we’re advancing preclinical research. 🧬acrobiosystems.com/A2398-Disease-… #Biotech #LifeSciences
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🔬 #CCR7 & #CCR8 are promising targets in #TumorImmunoregulation! CCR7 promotes lymph node metastasis, while CCR8 in Tregs suppresses antitumor immunity. ACROBiosystems offers full-length CCR7 & CCR8 proteins for targeted drug R&D. smpl.is/9rpp7 #CancerResearch

🔬 #CCR7 & #CCR8 are promising targets in #TumorImmunoregulation! CCR7 promotes lymph node metastasis, while CCR8 in Tregs suppresses antitumor immunity. ACROBiosystems offers full-length CCR7 & CCR8 proteins for targeted drug R&D. smpl.is/9rpp7 #CancerResearch
ACROBiosystems (@acrobio) 's Twitter Profile Photo

This season, we’re adding a little fun to your lab with our limited-edition Holiday Llama Keychain! 🦙✨ Place an order with us and claim this adorable companion for a dash of festive joy. 🔗acrobiosystems.com/A2624.html?utm…

ACROBiosystems (@acrobio) 's Twitter Profile Photo

📥 New whitepaper: Bispecific antibodies targeting immune checkpoints are reshaping #CancerTherapy! Learn how BsAbs boost immune responses, improve precision & reduce side effects. Download now: smpl.is/9s8fp #Biotech #Oncology

ACROBiosystems (@acrobio) 's Twitter Profile Photo

🧠 New Midbrain Organoids for #ParkinsonsResearch! Featuring TH, MAP2, FOXA2 & OTX2, our ready-to-use model supports deeper insights into PD pathology & therapies. Learn more: smpl.is/9sf6p #Neuroscience #Organoids #Biotech

🧠 New Midbrain Organoids for #ParkinsonsResearch! Featuring TH, MAP2, FOXA2 & OTX2, our ready-to-use model supports deeper insights into PD pathology & therapies. Learn more: smpl.is/9sf6p #Neuroscience #Organoids #Biotech
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🔬 The #Cadherin family is unlocking new precision ADC therapies in #CancerTreatment! Key in cell adhesion and signaling, Cadherins are emerging as prime ADC targets. Discover more: smpl.is/9sf7h #Immunotherapy #Biotech

🔬 The #Cadherin family is unlocking new precision ADC therapies in #CancerTreatment! Key in cell adhesion and signaling, Cadherins are emerging as prime ADC targets. Discover more: smpl.is/9sf7h #Immunotherapy #Biotech
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🔬 Combination therapies with ADCs are advancing #CancerTreatment! By pairing ADCs with chemo, radiation, targeted, or immunotherapy, researchers aim to enhance outcomes & overcome resistance. Learn more: smpl.is/9smsf #AntibodyDrugConjugates #Oncology

🔬 Combination therapies with ADCs are advancing #CancerTreatment! By pairing ADCs with chemo, radiation, targeted, or immunotherapy, researchers aim to enhance outcomes & overcome resistance. Learn more: smpl.is/9smsf #AntibodyDrugConjugates #Oncology
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🔬 STEAP1 is a promising target in solid tumor therapies like prostate & colorectal cancers. ACROBiosystems offers full-length STEAP1 proteins for developing CAR-T, ADCs, & bispecific antibodies. smpl.is/9td58 #STEAP1 #CancerTherapy #ADC #CART #Biotech

🔬 STEAP1 is a promising target in solid tumor therapies like prostate & colorectal cancers. ACROBiosystems offers full-length STEAP1 proteins for developing CAR-T, ADCs, & bispecific antibodies. smpl.is/9td58

#STEAP1 #CancerTherapy #ADC #CART #Biotech
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🦠 WHO-aligned influenza reagents for 2025 vaccines are here! Egg-based & cell-based options for H3N2 strains with HA & NA proteins. Learn more: smpl.is/9uckf #InfluenzaReagents #WHORecommendations #VaccineDevelopment #FluSeason #Biotech #AntigenQuantification

🦠 WHO-aligned influenza reagents for 2025 vaccines are here! Egg-based & cell-based options for H3N2 strains with HA & NA proteins. Learn more: smpl.is/9uckf #InfluenzaReagents #WHORecommendations #VaccineDevelopment #FluSeason #Biotech #AntigenQuantification
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🔬 Exploring #ADAM9—a pivotal protein in cancer and beyond! Its role in tumor progression and disease makes it a key therapeutic target. Discover innovative treatments like ADCs, inhibitors, and mRNA therapies: smpl.is/9uji4 #CancerResearch #Biotech

🔬 Exploring #ADAM9—a pivotal protein in cancer and beyond! Its role in tumor progression and disease makes it a key therapeutic target. Discover innovative treatments like ADCs, inhibitors, and mRNA therapies: smpl.is/9uji4

#CancerResearch #Biotech
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🌬️ Multi-target approaches are advancing #AsthmaTherapies! ACROBiosystems offers tools for TSLP, IL-4, IL-5, IL-13, IL-17, & IgE targeting to support innovative drug discovery. Learn more: smpl.is/9uu64 #Biotech #Inflammation

🌬️ Multi-target approaches are advancing #AsthmaTherapies! ACROBiosystems offers tools for TSLP, IL-4, IL-5, IL-13, IL-17, & IgE targeting to support innovative drug discovery. Learn more:  smpl.is/9uu64 #Biotech #Inflammation
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🔬 The TL1A-DR3 (TR-FRET) Kit by ACROBiosystems delivers high sensitivity & specificity for TL1A inhibitor screening. Accelerate drug discovery with ease! Learn more: smpl.is/9v6fa #TRFRET #Biotech #DrugDiscovery

🔬 The TL1A-DR3 (TR-FRET) Kit by ACROBiosystems delivers high sensitivity & specificity for TL1A inhibitor screening. Accelerate drug discovery with ease! Learn more: smpl.is/9v6fa #TRFRET #Biotech #DrugDiscovery
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🌟 #IL31 is a key target in dermatitis drug development. With nemolizumab FDA-approved, ACROBiosystems offers bioactive IL-31/IL-31RA proteins to advance discovery. Learn more: smpl.is/9wcec #Biotech #SkinHealth #DrugDiscovery

🌟 #IL31 is a key target in dermatitis drug development. With nemolizumab FDA-approved, ACROBiosystems offers bioactive IL-31/IL-31RA proteins to advance discovery. Learn more: smpl.is/9wcec #Biotech #SkinHealth #DrugDiscovery
ACROBiosystems (@acrobio) 's Twitter Profile Photo

🔬 #CD3 T-cell engagers target T/B antigens, enhancing B cell depletion & immune regulation in autoimmune therapies. Explore ACROBiosystems’ CD3 protein products for antibody R&D! smpl.is/9wjvf #Biotech #AntibodyTherapies

🔬 #CD3 T-cell engagers target T/B antigens, enhancing B cell depletion & immune regulation in autoimmune therapies. Explore ACROBiosystems’ CD3 protein products for antibody R&D! smpl.is/9wjvf #Biotech #AntibodyTherapies